{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:43:51Z","timestamp":1782225831159,"version":"3.54.5"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","license":[{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4,14]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>To evaluate, using meta-analysis, the efficacy and safety profile of Jinhua Qinggan granules (JHQG) in the treatment of novel coronavirus pneumonia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We screened multiple publication databases (PubMed, Embase, The Cochrane Library, Web of Science, CNKI, WanFang, and VIP), using parameters designed to identify articles detailing randomized controlled trials relating to the treatment of novel coronavirus pneumonia with JHQG. The inclusion period for each search was the point of database inception to November 2022. Each piece of literature identified in our initial screening was independently reviewed by 2 researchers, who extracted the relevant data and evaluated the bias risk associated with the study. The data was split in 2: the control group (containing patients who had received routine treatment or placebo) and the experimental group (containing patients treated with JHQG). The meta-analysis was performed using Revman 5.4 software. The quality of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation approach.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Four articles were selected for this study and combined included a total of 582 patients, which were subdivided into experimental (n\u2005=\u2005347) and control (n\u2005=\u2005235) groups. The results showed that treatment with JHQG could significantly: enhance the improvement rate of primary symptoms [relative ratio (RR)\u2005=\u20051.26,95% confidence interval (CI) (1.07, 1.49), <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.007] and fever [RR\u2005=\u20051.48, 95% CI (1.07, 2.04), <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.02]; decrease the viral nucleic acid in patients with coronavirus disease 2019 (COVID-19) [RR\u2005=\u20052.04, 95% CI (1.15, 3.62), <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.02] and reduce the progression of pneumonia [RR\u2005=\u20050.34, 95% CI (0.17, 0.67), <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.002]. However, there was no significant difference between the 2 groups with regards to: the improvement rate of cough, nausea and vomiting, fatigue, computed tomography, or frequency of adverse reactions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Current evidence indicates that JHQG is effective in treating COVID-19, increasing the rate of improvement for fever, increasing the negative rate of viral nucleic acid in patients with COVID-19 and reducing the aggravation rate of pneumonia. These conclusions need to be verified by further rigorous studies, as the existing results were limited by the number and quality of the included studies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000033545","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T14:06:21Z","timestamp":1681481181000},"page":"e33545","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy and safety of Jinhua Qinggan granules in the treatment of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis"],"prefix":"10.1097","volume":"102","author":[{"given":"Xiuying","family":"Si","sequence":"first","affiliation":[{"name":"Heilongjiang University of Chinese Medicine, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"Ma","sequence":"additional","affiliation":[{"name":"Jinan Zhangqiu District Hospital of Traditional Chinese Medicine, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youpeng","family":"Wang","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Li","sequence":"additional","affiliation":[{"name":"Heilongjiang University of Chinese Medicine, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujia","family":"Liu","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Guo","sequence":"additional","affiliation":[{"name":"Heilongjiang University of Chinese Medicine, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liang","sequence":"additional","affiliation":[{"name":"Heilongjiang University of Chinese Medicine, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxia","family":"Pan","sequence":"additional","affiliation":[{"name":"Heilongjiang University of Chinese Medicine, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"100537","DOI":"10.1016\/j.lanepe.2022.100537","article-title":"Effectiveness of the COVID-19 vaccines against hospitalisation with Omicron sub-lineages BA.4 and BA.5 in England.","volume":"23","author":"M\u00f8ller Kirsebom","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"e2115985","DOI":"10.1001\/jamanetworkopen.2021.15985","article-title":"Assessment of effectiveness of 1 dose of BNT162b2 vaccine for SARS-CoV-2 infection 13 to 24 days after immunization.","volume":"4","author":"Chodick","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R4-20250504","first-page":"1309","article-title":"Study on the incubation period of COVID-19 infected by different novel coronavirus variants.","volume":"25","author":"Wu","year":"2022","journal-title":"Chin Gen Pract Med"},{"key":"R5-20250504","first-page":"7458","article-title":"Clinical study on the intervention of traditional Chinese medicine on novel coronavirus pneumonia.","volume":"36","author":"Chai","year":"2021","journal-title":"Chin J Tradit Chin Med"},{"key":"R6-20250504","first-page":"283","article-title":"Analysis of clinical efficacy of traditional Chinese medicine combined with ribavirin and arbidol in the treatment of COVID-19.","author":"Hou","year":"2020","journal-title":"Everyone Healthy"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"101297","DOI":"10.1016\/j.ctcp.2020.101297","article-title":"Efficacy and safety of yinqiao powder combined with western medicine in the treatment of pneumonia: a systematic review and meta-analysis.","volume":"42","author":"Fan","year":"2021","journal-title":"Complement Ther Clin Pract"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/HM9.0000000000000019","article-title":"The rationale behind the four major anti-COVID-19 principles of Chinese herbal medicine based on systems medicine.","volume":"1","author":"Jin","year":"2021","journal-title":"Acupunct Herb Med"},{"key":"R11-20250504","first-page":"465","article-title":"Pharmacological action and clinical application of Chinese patent medicine for novel coronavirus pneumonia.","volume":"39","author":"Xiong","year":"2020","journal-title":"Med Guide"},{"key":"R12-20250504","first-page":"13","article-title":"Inspiration from the innovative experience of \u201cJinhua Qinggan Granules\u201d.","author":"Li","year":"2010","journal-title":"Invention and Innovation (Comprehensive Science and Technology)"},{"key":"R13-20250504","first-page":"446","article-title":"Identification of components and plasma of Jinhua Qinggan granuless and preliminary pharmacokinetics analysis (in Chinese).","volume":"57","author":"Zeng","year":"2022","journal-title":"Acta Pharm Sin"},{"key":"R14-20250504","first-page":"481","article-title":"Diagnosis and treatment of corona virus disease-19 (9th trial edition) (in Chinese).","volume":"17","year":"2022","journal-title":"Chin Med"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"728055","DOI":"10.3389\/fmed.2021.728055","article-title":"Efficacy of Jinhua Qinggan granuless combined with western medicine in the treatment of confirmed and suspected COVID-19: a randomized controlled trial.","volume":"8","author":"An","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R16-20250504","first-page":"1473","article-title":"Clinical observation on Jinhua Qinggan granules combined with conventional western medicine therapy in treating mild cases of coronavirus disease combined with conventional western medicine therapy in treating mild cases of coronavirus disease2019 (in Chinese).","volume":"61","author":"Duan","year":"2020","journal-title":"J Tradit Chin Med"},{"key":"R17-20250504","first-page":"467","article-title":"Effect of Jinhua Qinggan granuless on novel coronavirus pneumonia in patients.","volume":"40","author":"Liu","year":"2020","journal-title":"J Tradit Chin Med"},{"key":"R18-20250504","first-page":"779","article-title":"Study on the mechanism of huanglian jiedu decoction in treating novel coronavirus pneumonia based on network pharmacology.","volume":"43","author":"Huang","year":"2020","journal-title":"Chin Herb Med"},{"key":"R19-20250504","first-page":"1685","article-title":"Study on the potential pharmacodynamic substances of Jinhua Qinggan granules for preventing and treating novel coronavirus pneumonia based on network pharmacology and molecular docking technology.","volume":"51","author":"Gong","year":"2020","journal-title":"Chin Herb Med"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"e20531","DOI":"10.1097\/MD.0000000000020531","article-title":"The efficacy and safety of Jinhua Qinggan granules (JHQG) in the treatment of coronavirus disease 2019 (COVID-19): a protocol for systematic review and meta analysis.","volume":"99","author":"Zhang","year":"2020","journal-title":"Medicine (Baltim)"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"e20612","DOI":"10.1097\/MD.0000000000020612","article-title":"Efficacy and safety of Jinhua Qinggan granuless for coronavirus disease 2019 (COVID-19): a protocol of a systematic review and meta-analysis.","volume":"99","author":"Chen","year":"2020","journal-title":"Medicine (Baltim)"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R23-20250504","first-page":"ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions.","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"928468","DOI":"10.3389\/fmed.2022.928468","article-title":"Jinhua Qinggan granules for non-hospitalized COVID-19 patients: a double-blind, placebo-controlled, and randomized controlled trial.","volume":"9","author":"Shah","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1080\/14787210.2020.1797487","article-title":"Resolution of coronavirus disease 2019 (COVID-19).","volume":"18","author":"Habas","year":"2020","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1208\/s12248-020-00532-2","article-title":"Recent developments on therapeutic and diagnostic approaches for COVID-19.","volume":"23","author":"Majumder","year":"2021","journal-title":"AAPS J"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"m606","DOI":"10.1136\/bmj.m606","article-title":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series.","volume":"368","author":"Xu","year":"2020","journal-title":"BMJ"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"R29-20250504","first-page":"13","article-title":"A case series analysis of clinical characteristics of 54 COVID-19 patients in Ganzhou City, Jiangxi Province.","volume":"26","author":"Gong","year":"2022","journal-title":"Grassroots Med Forum"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/ageing\/afaa223","article-title":"Probable delirium is a presenting symptom of COVID-19 in frail, older adults: a cohort study of 322 hospitalised and 535 community-based older adults.","volume":"50","author":"Zazzara","year":"2021","journal-title":"Age Ageing"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"101205","DOI":"10.1016\/j.arr.2020.101205","article-title":"Aging in COVID-19: vulnerability, immunity and intervention.","volume":"65","author":"Chen","year":"2021","journal-title":"Ageing Res Rev"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41586-020-2918-0","article-title":"Age-specific mortality and immunity patterns of SARS-Co V-2.","volume":"590","author":"O\u2019Driscoll","year":"2021","journal-title":"Nature"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"111310","DOI":"10.1016\/j.biopha.2021.111310","article-title":"Research progress of traditional Chinese medicine against COVID-19.","volume":"137","author":"Ren","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"R35-20250504","first-page":"215","article-title":"Using network pharmacology to explore the mechanism of different Chinese patent medicines in the treatment of novel coronavirus pneumonia.","volume":"43","author":"Huang","year":"2022","journal-title":"J Air Force Mil Med Univ"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s10753-019-01035-9","article-title":"Inhibition of the PI3K\/AKT signaling pathway or overexpression of beclin1 blocks reinfection of streptococcus pneumoniae after infection of influenza a virus in severe community-acquired pneumonia.","volume":"42","author":"Yang","year":"2019","journal-title":"Inflammation"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1128\/AAC.03659-14","article-title":"Antiviral potential of ERK\/MAPK and PI3K\/AKT\/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis.","volume":"59","author":"Kindrachuk","year":"2015","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033545","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:39:57Z","timestamp":1746326397000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,14]]},"references-count":33,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000033545","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,14]]}}}